Musshoff Frank, Madea Burkhard
Institute of Legal Medicine, University Bonn, Bonn, Germany.
Ther Drug Monit. 2006 Apr;28(2):155-63. doi: 10.1097/01.ftd.0000197091.07807.22.
Especially for cannabinoids, analytical procedures for the verification of recent use and generally for the assessment of the extent of drug abuse are of interest in clinical and forensic toxicology. For confirmation of abstinence, urine analysis seems to be a useful tool. Serial monitoring of THC-COOH to creatinine ratios can differentiate between recent drug use and residual THC-COOH excretion (THC-COOH/creatinine ratio > or = 0.5 compared with previous specimen ratio). For an assessment of the extent of cannabis use, the determination of free and bound THC-COOH and especially of THC and 11-OH-THC glucuronides are suggested as useful but need further confirmation. Blood analysis is preferred for the interpretation of acute effects after cannabis abuse. The cannabis influence factor (CIF) was demonstrated as a better tool to interpret the concentrations of THC and its metabolites in blood in forensic cases and therefore it was proposed to assume absolute driving inability because of cannabis intoxication from a CIF > or = 10. Additionally, a higher CIF is indicative of a recent cannabis abuse. Also discrimination between occasional use of cannabis and regular drug consumption is possible by analysis of THC-COOH in blood samples because of the long plasma half-life of THC-COOH and its accumulation in the blood of frequent cannabis consumers. In routine tests, blood samples have to be taken within a prescribed 8-day-period, and a THC-COOH concentration >75 ng/mL is assumed to be associated with regular consumption of cannabis products, whereas plasma THC-COOH concentrations <5 ng/mL are associated with occasional consumption. In contrast to other illicit drugs, hair analysis lacks the sensitivity to act as a detector for cannabinoids. THC and especially the main metabolite THC-COOH have a very low incorporation rate into hair and THC is not highly bound to melanin, resulting in much lower concentrations in hair compared with other drugs. Additionally, THC is present in cannabis smoke and also can be incorporated into the hair only by contamination. For the determination of the main metabolite THC-COOH in the picogram or femtogram per milligram range, which indicates an active consumption, special analytical procedures, such as GC/MS/MS techniques, are required.
特别是对于大麻素而言,在临床和法医毒理学中,近期使用情况的验证以及一般药物滥用程度评估的分析程序备受关注。对于确认戒毒情况,尿液分析似乎是一种有用的工具。对四氢大麻酚酸(THC - COOH)与肌酐比值进行连续监测,可区分近期药物使用和残留的THC - COOH排泄情况(与先前样本比值相比,THC - COOH/肌酐比值≥0.5)。为评估大麻使用程度,建议测定游离和结合的THC - COOH,尤其是THC和11 - 羟基 - THC葡糖苷酸,它们虽有用但需进一步确认。血液分析更适合用于解释大麻滥用后的急性效应。大麻影响因子(CIF)被证明是法医案件中解释血液中THC及其代谢物浓度的更好工具,因此有人提议,当CIF≥10时,假定因大麻中毒而绝对无法驾驶。此外,较高的CIF表明近期有大麻滥用情况。由于THC - COOH的血浆半衰期长且在频繁使用大麻者的血液中会蓄积,通过分析血样中的THC - COOH,也能够区分偶尔使用大麻和经常吸毒的情况。在常规检测中,血样必须在规定的8天内采集,THC - COOH浓度>75 ng/mL被认为与经常使用大麻制品有关,而血浆THC - COOH浓度<5 ng/mL则与偶尔使用有关。与其他非法药物不同,毛发分析缺乏作为大麻素检测手段的灵敏度。THC尤其是主要代谢物THC - COOH在毛发中的掺入率非常低,且THC与黑色素的结合不紧密,导致毛发中的浓度与其他药物相比要低得多。此外,THC存在于大麻烟雾中,也只能通过污染掺入毛发。对于测定每毫克皮克或飞克范围内的主要代谢物THC - COOH(这表明正在使用大麻),需要特殊的分析程序,如气相色谱/串联质谱(GC/MS/MS)技术。